StockData
Encompass Health Corp logo

Encompass Health Corp (EHC) stock analysis

EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3014% above fair value
$142.51+1.36 (+0.96%)

Close on Nov 10, 2026Market cap $14.06BP/E 23.2Yield 0.51%

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth4Performance5Health3Dividend3

Solid16 of 30 checks passed

Encompass Health passes 16 of the 30 checks behind our score; 3 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
4/6
Past performance
5/6
Financial health
3/6
Dividend
3/6

What stands out

  • Return on equity over 15%

    Return on equity was 25.5% over the last twelve months and averaged 22.8% over five years.

  • Earnings grew over 5 years

    Net income grew 14.8% a year on average over the last five fiscal years.

  • Revenue growing 10%+ a year

    Revenue grew 10.9% a year over the last three fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 27.1% a year over the last three fiscal years.

What to watch

  • Margin of safety under 20%

    The price is 14.0% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $142.51 is above our fair value estimate of $125.04.

  • High debt

    Debt is 101% of shareholders' equity, above the 40% we consider low.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.97; above 3 is the safe zone and below 1.8 the distress zone.

Valuation1/6
  • P/E above its 5-year median

    Encompass Health's P/E of 23.2 is above its own 5-year median of 21.4.

  • P/E below the industry

    Encompass Health's P/E of 23.2 is below the Health Services median of 23.9.

  • EV/EBITDA above its 5-year median

    Encompass Health's EV/EBITDA of 11.6 is above its 5-year median of 11.2.

  • P/B above the industry

    Encompass Health's price-to-book of 5.41 is above the Health Services median of 3.52.

  • Trading above fair value

    The share price of $142.51 is above our fair value estimate of $125.04.

  • Margin of safety under 20%

    The price is 14.0% above fair value, so there is no margin of safety.

Growth4/6
  • Revenue growing 10%+ a year

    Revenue grew 10.9% a year over the last three fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 27.1% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 18.8% over the last twelve months, against a 5-year average of 14.8% a year.

  • Growing faster than the industry

    Revenue grew 9.5% over the last twelve months; the Health Services median is 4.0%.

  • Guidance lowered

    Encompass Health lowered its 2026 Amortization of debt-related items outlook on Aug 5, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance5/6
  • Return on equity over 15%

    Return on equity was 25.5% over the last twelve months and averaged 22.8% over five years.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity above the industry

    Encompass Health's return on equity of 25.5% is above the Health Services median of 4.6%.

  • Earnings grew over 5 years

    Net income grew 14.8% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 10.0% over the last twelve months, against a 5-year average of 8.4%.

  • Net margin above the industry

    Encompass Health's net margin of 10.0% is above the Health Services median of -2.6%.

Financial health3/6
  • High debt

    Debt is 101% of shareholders' equity, above the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 207% five years ago to 101%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 46.0% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 1.19 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.97; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    Encompass Health paid dividends worth 0.5% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.5% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Encompass Health yields 0.5%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Covered by earnings

    Dividends take 12.1% of net income.

  • Covered by free cash flow

    Dividends take 18.2% of free cash flow.

Scores of similar companies

Our estimate per share

$125.04

The share price is 14% above this estimate.

20%+ below
Near fair value
20%+ above
$142.51Price$125.04Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E22.7×21.4×23.9×$139.1544%
EV/EBITDA9.9×11.2×8.6×$125.3039%
Earnings power8.3% cost of equity––$86.7817%
Fair value$125.04100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 21.4
  • Health Services median 23.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$149.96M
Value traded per 1% price move
$108.46M

Downside

Low risk

Typical loss in a bad month
11.4%
Volatility (annualized)
31%
Sharpe ratio, 1 year
0.63
Beta to the S&P 500 (5Y)
0.68

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Operating margin

–

Net margin

9.5%+1.6 pts over 5 years

See a number that looks wrong?